| C07AB02 |
Metoprolol |
Metoprol tartrate Accord |
Tablet |
100 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
150 |
mg |
- |
4.64 |
0.232 |
4.64 |
50% |
2.32 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
КЦРР-868/26.06.2012 г.; НСР-947/12.08.2013.; НСР-7213/09.10.2015. и КП-398/25.11.2015. |
02.03.2016 |
08.09.2012 |
|
Активен |
1105 |
Без промяна |
| C07AB02 |
Metoprolol |
Metoprol tartrate Accord |
Tablet |
50 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
150 |
mg |
- |
10.44 |
0.232 |
2.32 |
50% |
1.16 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
КЦРР-868/26.06.2012 г.; НСР-946/12.08.2013 |
02.03.2016 |
08.09.2012 |
|
Активен |
1104 |
3.71 |
| C07AB02 |
Metoprolol |
METOSTAD |
Prolonged‐release tablet |
100 |
mg |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
9.28 |
0.232 |
4.64 |
50% |
2.32 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48 |
№ 48/ 09.02.2010; НСР-2503/24.01.2014 |
02.06.2016 |
08.09.2012 |
|
Активен |
2480 |
Без промяна |
| C07AB02 |
Metoprolol |
METOSTAD |
Prolonged‐release tablet |
50 |
mg |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
6.71 |
0.232 |
2.32 |
50% |
1.16 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48,I50.0,I50.1 |
№ 48/ 09.02.2010; НСР-3455/30.04.2014 |
02.03.2016 |
08.09.2012 |
|
Активен |
813 |
3.71 |
| C07AB02 |
Metoprolol |
METOSTAD |
Prolonged‐release tablet |
25 |
mg |
30 |
Stada Arzneimittel AG, Германия |
150 |
mg |
- |
4.48 |
0.232 |
1.16 |
50% |
0.58 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48,I50.0,I50.1 |
№ 48/ 09.02.2010; НСР-3455/30.04.2014 |
02.03.2016 |
08.09.2012 |
|
Активен |
812 |
1.86 |
| C07AB02 |
Metoprolol |
Succiprol 47.5 mg (съответстващ на 50 mg metoprolol tartrate) |
Prolonged‐release tablet |
50 |
mg |
60 |
Тева Фармасютикълс България ЕООД, България |
150 |
mg |
- |
10.97 |
0.232 |
4.64 |
50% |
2.32 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48,I50.0,I50.1 |
НСР-4584/15.09.2014 |
02.03.2016 |
|
|
Активен |
3169 |
7.42 |
| C07AB02 |
Metoprolol |
Succiprol 95 mg (съответстващ на 100 mg metoprolol tartrate) |
Prolonged‐release tablet |
100 |
mg |
60 |
Тева Фармасютикълс България ЕООД, България |
150 |
mg |
- |
21.41 |
0.232 |
9.28 |
50% |
4.64 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8,I45.6,I47.1,I48,I50.0,I50.1 |
НСР-4585/15.09.2014 |
02.03.2016 |
|
|
Активен |
3168 |
14.85 |
| C07AB02 |
Metoprolol |
Vasocardin 100 |
Tablet |
100 |
mg |
30 |
Zentiva a.s., Словакия |
150 |
mg |
- |
4.18 |
0.209 |
4.18 |
50% |
2.09 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I10,I11,I12,I13,I20,I45.6,I47.1,I48 |
НСР-1357/07.10.2013 |
02.11.2013 |
08.09.2012 |
|
Заличен |
277 |
|
| C07AB02 |
Metoprolol |
Vasocardin 50 |
Tablet |
50 |
mg |
30 |
Zentiva a.s., Словакия |
150 |
mg |
- |
2.99 |
0.209 |
2.09 |
50% |
1.05 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I10,I11,I12,I13,I20,I45.6,I47.1,I48 |
НСР-1356/07.10.2013 |
02.11.2013 |
08.09.2012 |
|
Заличен |
276 |
|
| C07AB03 |
Atenolol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C07AB03 |
Atenolol |
ATENOLOL ACTAVIS |
Film‐coated tablet |
25 |
mg |
30 |
Актавис EАД, България |
75 |
mg |
- |
1.75 |
0.122 |
1.22 |
50% |
0.61 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
НСР-6394/03.06.2015. |
02.07.2015 |
08.09.2012 |
|
Активен |
241 |
Без промяна |
| C07AB03 |
Atenolol |
ATENOLOL ACTAVIS |
Film‐coated tablet |
25 |
mg |
30 |
Актавис EАД, България |
75 |
mg |
- |
1.75 |
0.122 |
1.22 |
50% |
0.61 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I10,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
НСР-6393/03.06.2015 |
02.07.2015 |
08.09.2012 |
|
Заличен |
241 |
|
| C07AB03 |
Atenolol |
ATENOLOL ACTAVIS |
Film‐coated tablet |
50 |
mg |
30 |
Актавис EАД, България |
75 |
mg |
- |
2.44 |
0.122 |
2.44 |
50% |
1.22 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
|
|
08.09.2012 |
|
Активен |
242 |
Без промяна |
| C07AB03 |
Atenolol |
ATENOLOL SOPHARMA |
Film‐coated tablet |
25 |
mg |
30 |
Софарма АД, България |
75 |
mg |
- |
1.28 |
0.122 |
1.22 |
50% |
0.61 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
|
|
08.09.2012 |
|
Активен |
174 |
Без промяна |
| C07AB03 |
Atenolol |
ATENOLOL SOPHARMA |
Film‐coated tablet |
50 |
mg |
30 |
Софарма АД, България |
75 |
mg |
- |
2.44 |
0.122 |
2.44 |
50% |
1.22 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
|
|
08.09.2012 |
|
Активен |
173 |
Без промяна |
| C07AB03 |
Atenolol |
ATENOLOL-TCHAIKAPHARMA |
Tablet |
50 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
75 |
mg |
- |
2.44 |
0.122 |
2.44 |
50% |
1.22 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
|
|
08.09.2012 |
|
Активен |
566 |
Без промяна |
| C07AB07 |
Bisoprolol hemifumarate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C07AB07 |
Bisoprolol |
Bibloc |
Film‐coated tablet |
5 |
mg |
30 |
Sandoz d.d., Словения |
10 |
mg |
- |
3.88 |
0.08633 |
1.29 |
50% |
0.64 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8 |
КЦРР-1726/04.12.2012 г.; НСР-5515/29.01.2015; КП-236/11.05.2015 и НСР-2766/17.02.2014.; HCP-8619/31.03.2016; Решение на ВАС № 8280/05.07.2016 |
42584 |
|
|
Активен |
3905 |
2.06 |
| C07AB07 |
Bisoprolol |
Bibloc |
Film‐coated tablet |
10 |
mg |
30 |
Sandoz d.d., Словения |
10 |
mg |
- |
6.3 |
0.08633 |
2.59 |
50% |
1.29 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8 |
КЦРР-1726/04.12.2012.; HCP-8619/31.03.2016. |
02.07.2016 |
|
|
Активен |
1473 |
4.14 |
| C07AB07 |
Bisoprolol |
Biprol |
Film‐coated tablet |
10 |
mg |
30 |
Нео Балканика ЕООД, България |
10 |
mg |
- |
10.67 |
0.08633 |
2.59 |
50% |
1.29 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8 |
НСР-3026/21.03.2014 |
02.07.2016 |
|
|
Активен |
2610 |
4.14 |
| C07AB07 |
Bisoprolol |
Biprol |
Film‐coated tablet |
5 |
mg |
30 |
Нео Балканика ЕООД, България |
10 |
mg |
- |
7.39 |
0.08633 |
1.29 |
50% |
0.64 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8 |
НСР-3026/21.03.2014 |
02.07.2016 |
|
|
Активен |
2609 |
2.06 |
| C07AB07 |
Bisoprolol |
BISOGAMMA 10 |
Film‐coated tablet |
10 |
mg |
50 |
Woerwag Pharma GmbH & Co.KG, Германия |
10 |
mg |
- |
13.03 |
0.08633 |
4.32 |
50% |
2.16 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8 |
КЦРР-842/15.06.2012 г.; НСР-3109/26.03.2014 |
02.07.2016 |
08.09.2012 |
|
Активен |
2635 |
6.91 |
| C07AB07 |
Bisoprolol |
BISOGAMMA 10 |
Film‐coated tablet |
10 |
mg |
30 |
Woerwag Pharma GmbH & Co.KG, Германия |
10 |
mg |
- |
5.3 |
0.08633 |
2.59 |
50% |
1.29 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8 |
КЦРР-842/15.06.2012 г.;НСР-1393/10.10.2013; НСР-7759/28.12.2015 |
02.07.2016 |
08.09.2012 |
|
Активен |
2171 |
Без промяна |
| C07AB07 |
Bisoprolol |
BISOGAMMA 5 |
Film‐coated tablet |
5 |
mg |
50 |
Woerwag Pharma GmbH & Co.KG, Германия |
10 |
mg |
- |
6.53 |
0.08633 |
2.16 |
50% |
1.08 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8 |
КЦРР-841/15.06.2012 г. |
02.07.2016 |
08.09.2012 |
|
Активен |
1269 |
3.46 |
| C07AB07 |
Bisoprolol |
BISOGAMMA 5 |
Film‐coated tablet |
5 |
mg |
30 |
Woerwag Pharma GmbH & Co.KG, Германия |
10 |
mg |
- |
3.06 |
0.08633 |
1.29 |
50% |
0.64 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I20.0,I20.8 |
КЦРР-841/15.06.2012 г.; НСР-1393/10.10.2013 |
02.07.2016 |
08.09.2012 |
|
Активен |
2170 |
2.06 |